| 摘要 |
<p>The invention relates to the use of the CD 24 marker gene in mammals, such as the human CD24 human gene, for the transformation of keratinocyte stem cells when carrying out methods for preparing homogeneous batches of epidermal stem cells transformed in such a way that they contain an exogenous nucleotide sequence of interest, in addition to said transformed keratinocyte stem cells, epidermal tissue reconstituted from said keratinocytes and the uses thereof.</p> |
